Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy

Biochemical and Biophysical Research Communications

Volumn 399, Issue 2, 2010, Pages 144-149

  Tokunaga, Koki ^a   Uto, Hirofumi ^a   Takami, Yoichiro ^a   Mera, Kumiko ^a   Nishida, Chika ^a   Yoshimine, Yozo ^a   Fukumoto, Mayumi ^a   Oku, Manei ^a   Sogabe, Atsushi ^a   Nosaki, Tsuyoshi ^a   Moriuchi, Akihiro ^a   Oketani, Makoto ^a   Ido, Akio ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

IgA nephropathy; IGF 1; IGFBP 1; Mesangial cell proliferation; Serum level

Indexed keywords

IMMUNOGLOBULIN A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNOGLOBULIN A NEPHROPATHY; MESANGIUM CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KIDNEY; MALE; MICE; MICE, INBRED STRAINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

ANIMALIA; MUS;

EID: 77955845978     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.032     Document Type: Article

References (34)

1. Berger J., Hinglais N. Intercapillary deposits of IgA-IgG. J. Urol. Nephrol. 1968, 74:694-695.
2. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 2000, 36:227-237.
3. Jonathan B., John F. IgA nephropathy. J. Am. Soc. Nephrol. 2005, 16:2088-2097.
4. Muso E., Yoshida H., Takeuchi E., et al. Enhanced production of glomerular extracellular matrix in a new mouse stain of high serum IgA ddy mice. Kidney Int. 1996, 50:1946-1957.
5. Katsuma S., Shiojima S., Hirasawa A., et al. Genomic analysis of a mouse model of immunoglobulin A nephropathy reveals an enhanced PDGF-EDG5 cascade. Phermacogenomics J. 2001, 1:211-217.
6. Yoshimura H., Ito M., Kuwahara Y., et al. Downregulated expression in high IgA mice and the renal protective role of meprinβ. Life Sci. 2008, 82:899-908.
7. Yoshimura H., Sakai T., Kuwahara Y., et al. Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Exp. Mol. Pathol. 2009, 87:70-75.
8. Rajaram S., David J.B., Subburaman M. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 1997, 18:801-831.
9. Flyvbjerg A. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int. 1997, 52:S12-S19.
10. Doublier S., Seurin D., Fouqueray B., et al. Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1. Kidney Int. 2000, 57:2299-2307.
11. Hotta O., Furuta T., Chiba S., et al. Regression of IgA nephropathy: a repeat biopsy study. Am. J. Kidney Dis. 2002, 39:493-502.
12. Firth S., Baxter R. Cellular actions of the insulin-like growth factor binding proteins. Endoc. Rev. 2002, 23:824-854.
13. Katsaros D., Yu H., Levesque M.A., et al. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur. J. Cancer 2001, 37:478-485.
14. Rajaraman D., Yang W., Gupta S., et al. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int. J. Colorectal Dis. 2005, 20:203-220.
15. Pilewski J.M., Liu L., Henry A.C., et al. Insulin-like growth factor binding protein 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 2005, 166:399-407.
16. Yasuoka H., Jukic D.M., Zhou Z., et al. Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis Rheum. 2006, 54:3001-3010.
17. Holly J.M.P., Biddlecombe R.A., Dunger D.B., et al. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A. New role for insulin?. Clin. Endocrinol(Oxf). 1988, 29:667-675.
18. Rutanen E.M., Karkkainen T., Stenman U.H., et al. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J. Clin. Endocrinol. Metab. 1993, 77:1152-1155.
19. Ismail I.S., Miell J.P., Scanion M.F., et al. Effects of cholinergic modulation on serum insulin-like growth factor 1 and its binding proteins in normal and diabetic subjects. Clin. Endocrinol(Oxf). 1995, 42:147-152.
20. Akturk M., Arslan M., Altinova A., et al. Association of serum levels of IGF-1 and IGFBP-1 with renal function in patients with type 2 diabetes mellitus. Growth horm. IGF. Res. 2007, 17:186-193.
21. Frystyk J., Ivarsen P., Skjaerbaek C., et al. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999, 56:2076-2084.
22. Tonshoff B., Blum W.F., Wingen A.M., et al. Serum insulin-like growth factors (IGFs) and IGF binding Proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J. Clin. Endocrinol. Metab. 1995, 80:2684-2691.
23. Richmond E.J., Uzri A., Rogol A.D. The insulin-like growth factor system in kidney diseases. Nephron. 2001, 89:5-9.
24. Zha Y., Le V.T., Higami Y., et al. Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage. Endocrinology 2006, 147:5690-5698.
25. Fine R.N. Growth hormone and the kidney: the use of recombinant human growth hormone (rhGH) in growth-related children with chronic renal insufficiency. J. Am. Soc. Nephrol. 1991, 1:1139-1145.
26. el Nahas A.M. The role of growth hormone and insulin-like growth factor-1 in experimental renal growth and scarring. Am. J. Kidney Dis. 1991, 17:677-679.
27. Quaife C.J., Mathews L.S., Pinkert C.A., et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989, 124:40-48.
28. Feldt-Rasmussen B., El Nahas M. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease. Semin. Nephrol. 2009, 29:50-58.
29. He C., Esposito C., Phillips C., et al. Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J. Clin. Invest. 1996, 97:1242-1249.
30. Rechler M.M. Insulin-like growth factor binding proteins. Vitam. Horm. 1993, 47:1-114.
31. Lee P.D., Giudice L.C., Conover C.A., et al. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exp. Biol. Med. 1997, 216:319-357.
32. Tonshoff B., Kiepe D., Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr. Nephrol 2005, 20:279-289.
33. Hirschberg R., Adler S. Insulin-like growth factor system and kidney: physiology pathophysiology, and therapeutic implication. Am. J. Kidney Dis. 1998, 31:901-919.
34. Chin E., Bondy C. Insulin-like growth factor system gene expression in the human kidney. J. Clin. Endocrinol. Metab. 1992, 75:962-968.